Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines—a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261–279 (2018).
Hajj, K. A. et al. A potent branched-tail lipid nanoparticle enables multiplexed mRNA delivery and gene editing in vivo. Nano Lett. 20, 5167–5175 (2020).
Finn, J. D. et al. A single administration of CRISPR/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep/ 22, 2455–2468 (2018).
Walsh, G. & Walsh, E. Biopharmaceutical benchmarks 2022. Nat. Biotechnol. 40, 1722–1760 (2022).
Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078–1094 (2021).
Hammel, M. et al. Correlating the structure and gene silencing activity of oligonucleotide-loaded lipid nanoparticles using small-angle X-ray scattering. ACS Nano 17, 11454–11465 (2023).
Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948–6951 (2012).
Leung, A. K. K. et al. Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core. J. Phys. Chem. C 116, 18440–18450 (2012).
Shepherd, S. J. et al. Scalable mRNA and siRNA lipid nanoparticle production using a parallelized microfluidic device. Nano Lett. 21, 5671–5680 (2021).
Hallan, S. S., Sguizzato, M., Esposito, E. & Cortesi, R. Challenges in the physical characterization of lipid nanoparticles. Pharmaceutics 13, 1–31 (2021).
Henrickson, A. et al. Density matching multi-wavelength analytical ultracentrifugation to measure drug loading of lipid nanoparticle formulations. ACS Nano 15, 5068–5076 (2021).
Sych, T. et al. High-throughput measurement of the content and properties of nano-sized bioparticles with single-particle profiler. Nat. Biotechnol. 42, 587–590 (2024).
Li, S. et al. Payload distribution and capacity of mRNA lipid nanoparticles. Nat. Commun. 13, 5561 (2022).
Li, S. et al. Single-particle spectroscopic chromatography reveals heterogeneous RNA loading and size correlations in lipid nanoparticles. ACS Nano 18, 15729–15743 (2024).
Dao, H. M. et al. Characterization of mRNA lipid nanoparticles by electron density mapping reconstruction: X-ray scattering with density from solution scattering (DENSS) algorithm. Pharm. Res. 41, 501–512 (2024).
Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084–1087 (2019).
Hogan, M. J. & Pardi, N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu. Rev. Med. 73, 17–39 (2022).
Love, K. T. et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl Acad. Sci. USA 107, 1864–1869 (2010).
Guerrini, G., Mehn, D., Scaccabarozzi, D., Gioria, S. & Calzolai, L. Analytical ultracentrifugation to assess the quality of LNP-mRNA therapeutics. Int. J. Mol. Sci. 25, 5718 (2024).
Thaller, A. et al. SV-AUC as a stability-indicating method for the characterization of mRNA-LNPs. Eur. J. Pharm. Biopharm. 182, 152–156 (2023).
Schuck, P. & Rossmanith, P. Determination of the sedimentation coefficient distribution by least-squares boundary modeling. Biopolymers 54, 328–341 (2000).
Zhao, H., Sousa, A. A. & Schuck, P. Flotation coefficient distributions of lipid nanoparticles by sedimentation velocity analytical ultracentrifugation. ACS Nano 18, 18663–18672 (2024).
Jia, X. et al. Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations. J. Chromatogr. B 1186, 123015 (2021).
Some, D., Amartely, H., Tsadok, A. & Lebendiker, M. Characterization of proteins by size-exclusion chromatography coupled to multi-angle light scattering. J. Vis. Exp. 148, e59615 (2019).
Gao, Z. et al. Development of an advanced separation and characterization platform for mRNA and lipid nanoparticles using multi-detector asymmetrical flow field-flow fractionation. Anal. Bioanal. Chem. 416, 5281–5293 (2024).
Graewert, M. A. et al. Quantitative size-resolved characterization of mRNA nanoparticles by in-line coupling of asymmetrical-flow field-flow fractionation with small angle X-ray scattering. Sci. Rep. 13, 15764 (2023).
Kulkarni, C. V., Yaghmur, A., Steinhart, M., Kriechbaum, M. & Rappolt, M. Effects of high pressure on internally self-assembled lipid nanoparticles: a synchrotron small-angle X-ray scattering (SAXS) study. Langmuir 32, 11907–11917 (2016).
Uebbing, L. et al. Investigation of pH-responsiveness inside lipid nanoparticles for parenteral mRNA application using small-angle X-ray scattering. Langmuir 36, 13331–13341 (2020).
Meisburger, S. P., Xu, D. & Ando, N. REGALS: a general method to deconvolve X-ray scattering data from evolving mixtures. IUCrJ 8, 225–237 (2021).
Hura, G. L. et al. Comprehensive macromolecular conformations mapped by quantitative SAXS analyses. Nat. Methods 10, 453–454 (2013).
Guimaraes, P. P. G. et al. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening. J. Control. Release 316, 404–417 (2019).
Rhym, L. H., Manan, R. S., Koller, A., Stephanie, G. & Anderson, D. G. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery. Nat. Biomed. Eng. 7, 901–910 (2023).
DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).
Banushi, B., Joseph, S. R., Lum, B., Lee, J. J. & Simpson, F. Endocytosis in cancer and cancer therapy. Nat. Rev. Cancer 23, 450–473 (2023).
Thanh Cong, V. et al. How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells? Chem. Soc. Rev. 51, 7531–7559 (2022).
Sedic, M. et al. Safety evaluation of lipid nanoparticle–formulated modified mRNA in the Sprague–Dawley rat and cynomolgus monkey. Vet. Pathol. 55, 341–354 (2018).
Whitehead, K. A. et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 5, 4277 (2014).
Mrksich, K. et al. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length. J. Biomed. Mater. Res. A 112, 1494–1505 (2024).
Mrksich, K., Padilla, M. S. & Mitchell, M. J. Breaking the final barrier: evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome. Adv. Drug Deliv. Rev. 214, 115446 (2024).
Lindsay, S., Hussain, M., Binici, B. & Perrie, Y. Exploring the challenges of lipid nanoparticle development: the in vitro–in vivo correlation gap. Vaccines 13, 339 (2025).
Shepherd, S. J. et al. Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines. Proc. Natl Acad. Sci. USA 120, e2303567120 (2023).
Witten, J. et al. Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02490-y (2024).
Madathiparambil Visalakshan, R. et al. The influence of nanoparticle shape on protein corona formation. Small 16, 2000285 (2020).
Li, Z. et al. Shape effect of glyco-nanoparticles on macrophage cellular uptake and immune response. ACS Macro Lett. 5, 1059–1064 (2016).
Vácha, R., Martinez-Veracoechea, F. J. & Frenkel, D. Receptor-mediated endocytosis of nanoparticles of various shapes. Nano Lett. 11, 5391–5395 (2011).
Han, X. et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat. Nanotechnol. 18, 1105–1114 (2023).
Zhang, Y. et al. Not all cells are created equal—endosomal escape in fluorescent nanodiamonds in different cells. Nanoscale 13, 13294–13300 (2021).
Chatterjee, S., Kon, E., Sharma, P. & Peer, D. Endosomal escape: a bottleneck for LNP-mediated therapeutics. Proc. Natl Acad. Sci. USA 121, e2307800120 (2024).
Karikó, K., Muramatsu, H., Ludwig, J. & Weissman, D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 39, e142 (2011).
Schuck, P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78, 1606–1619 (2000).
DiFabio, J. et al. The Life Science X-ray Scattering beamline at NSLS-II. In Proc. 12th International Conference on Synchrotron Radiation Instrumentation Vol. 1741 (eds Chubar, O. et al.) 030049 (AIP, 2016).
Yang, L. et al. Tools for supporting solution scattering during the COVID-19 pandemic. J. Synchrotron Rad. 28, 1237–1244 (2021).
Yang, L. et al. Solution scattering at the Life Science X-ray Scattering (LiX) beamline. J. Synchrotron Rad. 27, 804–812 (2020).
Hopkins, J. B., Gillilan, R. E. & Skou, S. BioXTAS RAW: improvements to a free open-source program for small-angle X-ray scattering data reduction and analysis. J. Appl. Crystallogr. 50, 1545 (2017).
Maeder, M. Evolving factor analysis for the resolution of overlapping chromatographic peaks. Anal. Chem. 59, 527–530 (1987).
Svergun, D. I. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Cryst. 25, 495–503 (1992).
Semenyuk, A. V. & Svergun, D. I. GNOM—a program package for small-angle scattering data processing. J. Appl. Cryst. 24, 537–540 (1991).
Johansen, D., Trewhella, J. & Goldenberg, D. P. Fractal dimension of an intrinsically disordered protein: small-angle X-ray scattering and computational study of the bacteriophage λ N protein. Protein Sci. 20, 1955–1970 (2011).
Grant, T. D. Ab initio electron density determination directly from solution scattering data. Nat. Methods 15, 191–193 (2018).
Padilla, M. & Gupta, K. SV-AUC, FFF–MALS, SEC–SAXS datasets for ‘Elucidating lipid nanoparticle properties and structure through biophysical analyses’. Zenodo https://doi.org/10.5281/zenodo.17042311 (2025).
